Dublin, June 28, 2019 (GLOBE NEWSWIRE) -- The "Global Sinusitis Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

In 2018, steroid nasal sprays segment had a significant share market share, and this trend is expected to continue over the forecast period.

Factors such as the higher therapeutic efficacy are playing a significant role in the steroid nasal sprays segment to maintain its market position. Also, the report looks at factors such as the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions.

However, surgical intervention for sinusitis management, unknown etiology of sinusitis, and the launch of generics may hamper the growth of the sinusitis drugs industry over the forecast period.

Rising prevalence of sinusitis

Risk factors such as the history of respiratory tract infection, structural problems within the sinus glands, and nasal polyps have increased the prevalence of sinusitis in general population. Other factors, such as allergies, pollutants, and fungal infections, also cause sinus infections.

In 2017, a significant number of adults in the US were diagnosed with sinusitis. The prevalence of the infection was found to be higher in males than in females. The growing prevalence of sinusitis has increased the consumption of sinusitis treatment drugs. This is one of the key factors driving the growth of the global sinusitis drugs market size at a CAGR of over 6% during the forecast period.

Emergence of novel therapeutic approaches

The growing demand for targeted drugs for sinusitis is encouraging market vendors to develop novel therapies. Some vendors in the market are developing bacteriophage therapeutics that targets Staphylococcus aureus, including its antibiotic-resistant strains. These drugs are currently in Phase I/II stage of development. The advent of many such novel therapeutic approaches is expected to fuel the growth of the global sinusitis drugs market size.

Competitive Landscape

With the presence of several players, the global sinusitis drugs market is fairly fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several sinusitis drug companies.

Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Key Players

• CHIESI Farmaceutici S.p.A.
• GlaxoSmithKline PLC
• Intersect ENT Inc.
• Merck & Co. Inc.
• Sanofi

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: PIPELINE ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

• Comparison by product
• Steroid nasal sprays - Market size and forecast 2018-2023
• Antibiotics - Market size and forecast 2018-2023
• Decongestants - Market size and forecast 2018-2023
• Other drugs - Market size and forecast 2018-2023
• Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• RoW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• CHIESI Farmaceutici S.p.A.
• GlaxoSmithKline PLC
• Intersect ENT Inc.
• Merck & Co. Inc.
• Sanofi

For more information about this report visit https://www.researchandmarkets.com/r/8k04hl

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Cough and Cold Drugs

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.